Observational Study Open Access
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Pediatr. Jun 9, 2025; 14(2): 100614
Published online Jun 9, 2025. doi: 10.5409/wjcp.v14.i2.100614
Drug prescribing pattern in upper respiratory tract infections among the pediatric population attending outpatient clinics in pediatric hospitals
Amir F Kamal, Eman A Abdelaziz, Mohamed H Saad, Mai Badr, Department of Pediatrics, Faculty of Medicine, Cairo University, Cairo 02, Al Qāhirah, Egypt
Veronia F Fahim, Department of Medical Pharmacology, Faculty of Medicine, Cairo University, Cairo 02, Al Qāhirah, Egypt
ORCID number: Veronia F Fahim (0000-0002-0228-7178).
Author contributions: Kamal AF, Abdelaziz EA, and Badr M were responsible for conceiving the study; Saad MH was responsible for the methodology; Kamal AF, Abdelaziz EA, Saad MH, and Badr M were responsible for the data collection; Kamal AF, Fahim VF, Saad MH, and Badr M were responsible for writing and editing the manuscript; Abdelaziz EA was responsible for supervising the study; All authors have read and agreed to the published version of the manuscript.
Institutional review board statement: The study was reviewed and approved by the Faculty of Medicine, Cairo University Institutional Review Board on August 15, 2018.
Informed consent statement: All study participants, or their legal guardians, provided informed written consent before enrollment in the study.
Conflict-of-interest statement: The authors have no conflicts of interest to declare.
STROBE statement: The authors have read the STROBE Statement-checklist of items, and the manuscript was prepared and revised according to the STROBE Statement-checklist of items.
Data sharing statement: No additional data are available.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Veronia F Fahim, PhD, Department of Medical Pharmacology, Faculty of Medicine, Cairo University, Kasralainy, Cairo 02, Al Qāhirah, Egypt. veronia.fawzy@kasralainy.edu.eg
Received: August 21, 2024
Revised: December 2, 2024
Accepted: December 23, 2024
Published online: June 9, 2025
Processing time: 208 Days and 23.1 Hours

Abstract
BACKGROUND

Upper respiratory tract infections (URTIs) are one of the most frequent causes of childhood school leave and morbidity.

AIM

To study the present trend of medications’ prescribing pattern utilized in URTIs among the pediatric population attending outpatient clinics in pediatric hospitals.

METHODS

This analytical observational cross-sectional research was conducted in 200 children aged 1–10 years with URTIs attending the pediatric outpatient clinics in pediatric hospitals, one of which is an educational hospital, from July 2018 to August 2020.

RESULTS

Most of the prescriptions in our study included antibiotics (116/58%). The most commonly prescribed antibiotic family was ampicillin/sulbactam or amoxicillin/clavulanic acid (53/26.5%), followed by first-generation cephalosporin (25/12.5%) and third-generation cephalosporin (20/10%). Macrolides and second-generation cephalosporins were prescribed less frequently, in 16 (8%) and 2 (1%) patients, respectively. Most of our study population (155/77.5%) was satisfied with their prescriptions, whereas the rest of the study population (45/22.5%) was unsatisfied.

CONCLUSION

Overprescription of antibiotics is a significant issue among clinicians in pediatric outpatient clinics. Stewardship of drugs, particularly antibiotics, is a must to prevent the development of drug resistance. Most cases of URTIs were treated in accordance with the existing national treatment guidelines.

Key Words: Upper respiratory tract infection; Antibiotics’ prescribing pattern; School leave; Pediatric; Antibiotics’ stewardship

Core Tip: Overprescription of antibiotics is a significant issue among clinicians in pediatric outpatient clinics. Pediatric clinicians should aim to reduce antibiotic use by addressing three fundamental questions for each patient with a suspected infection: (1) Do antibiotics need to be prescribed; (2) What is the appropriate dose thereof; and (3) What is the optimal duration of treatment. Stewardship of drugs, particularly antibiotics is a must, to prevent the development of drug resistance.



INTRODUCTION

Acute respiratory illnesses are common in school-aged children, with approximately 30%-40% affected during the winter months. Upper respiratory tract infections (URTIs) are among the most prevalent causes of childhood school leave and morbidity, as well as the most frequent reasons for outpatient department (OPD) consultation. URTIs remain the clinical category for which antibiotics are most commonly prescribed. However, most URTIs are caused by viruses for which antibiotics have no role in treatment[1].

Bacterial etiology has been identified in just 10% of URTIs. The worldwide inappropriate usage of antibiotics in children with URTIs contributes to antibiotic resistance, which has become a serious public health problem. The consequences of antibiotic resistance are challenging to predict, but it is estimated that by 2050, it will cause about 10 million deaths and lead to a massive economic burden[2]. In 2019, the World Health Organization recognized antimicrobial resistance as one of the top 10 threats to global health[3].

The most common bacterial agents responsible for acute sinusitis are Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. Other organisms including Staphylococcus aureus, S. pyogenes, Gram-negative organisms, and anaerobes have also been recovered. Chronic sinusitis is commonly a mixed infection of aerobic and anaerobic organisms. Group A beta-hemolytic Streptococcus or St. pyogenes is the most important bacterial agent associated with acute pharyngitis and tonsillitis. Corynebacterium diphtheriae causes occasional cases of acute pharyngitis, as do mixed anaerobic infections (Vincent's angina), C. haemolyticum, Neisseria gonorrhoeae, and Chlamydia trachomatis. Outbreaks of Chlamydia pneumoniae (TWAR agent) causing pharyngitis or pneumonitis have occurred[4].

The initial treatment for cases diagnosed with bacterial URTIs is amoxicillin/clavulanic acid, while ceftriaxone is the preferred choice for those who are penicillin-sensitive. Other antibiotics that may be employed to treat URTIs include cefuroxime, cefpodoxime, azithromycin, cefdinir, cefixime, and cefadroxil[5].

The penicillin family of antibiotics remains a crucial component of our antimicrobial arsenal. These agents are generally well-distributed throughout the body, exhibit bactericidal activity, have low toxicity, and are effective against infections caused by susceptible bacteria[6]. A major pharmacologic milestone was the introduction of aqueous penicillin G for treating staphylococcal and streptococcal infections. In response to the emergence of penicillinase-producing S.aureus, penicillinase-resistant penicillins such as oxacillin, methicillin, and nafcillin were developed. These penicillins feature an acyl side chain that protects the β-lactam ring from disruption[7].

MATERIALS AND METHODS

This analytical cross-sectional research was performed on 200 kids aged 1–10 years with URTIs attending the pediatric outpatient clinics in pediatric hospitals, one of which is an educational hospital, from July 2018 to August 2020.

Inclusion criteria

Children with ages ranging from 1 to 10 years with URTIs.

Exclusion criteria

All patients between 1 and 10 years of age who attended the pediatric OPD and were diagnosed with URTIs were involved in the research, except those with intellectual disabilities, unconscious, and untreated cases; infants and kids with lower respiratory tract infections; infants and children with any other infections except URTIs; and those who needed inpatient admission.

Ethical considerations

The study was designed to confirm the requirements of the revised Helsinki Declaration of Bioethics (2013). The study protocol was presented to the Research Ethics Committee of the Faculty of Medicine, Cairo University for approval. Informed consent was obtained from the participants before enrollment in the study. The patients had the right to withdraw from the study at any time and for any reason without any consequences. Confidentiality of the data collected was protected.

Methods

The data were collected using an interview-based questionnaire. This data included a full medical history, vaccination history, physical examination involving anthropometry, laboratory investigations, and treatment given to children. The following was done based on the above-mentioned; the demographic characteristics of kids with URTIs were analyzed, focusing on the diagnosis and pharmacological information. This included the name of the drug (both its generic and brand names), dosage form, frequency of administration, duration of treatment, distribution of drug groups, antibiotics, and analgesic-antipyretics prescribed to the kids with URTIs.

Outcome measures

Primary outcome: Assessment of the pattern and rationale of drug prescription for URTIs in kids aged 1–10 attending outpatient clinics in pediatric hospitals.

Secondary outcomes: The prevalence of irrational drug use among children with URTIs; the correlation between antibiotic administration in kids with URTIs and their laboratory investigations; the correlation between the degree of fever and prescribing antibiotics for children; the correlation among children’s prescribed antibiotics, their temperature, and the extent of improvement of their condition; and the prevalence of prescribed antibiotics in kids with URTIs and antibiotic abuse.

Statistical analysis

The Excel 2013 program was used to acquire, code, and enter the data into the computer. The data analysis was conducted using the Statistical Package for the Social Sciences program. The data were analyzed and presented as percentages and numbers in tables and graphs; with a 95% confidence interval. The P value of 0.05 was utilized as the threshold for statistical significance. The quantitative values were given by the Student’s t-test, while the qualitative values were given by the χ2 test. The results were tabulated, and statistical significance was determined.

RESULTS

Table 1 shows that 52.0% of the studied patients were males. In total, 29.5% of the participants had acute pharyngitis, 19.0% had acute tonsillitis, 13.5% had acute sinusitis, 6.5% had acute otitis media, and 31.5% had acute rhinitis and/or common cold. Seventy percent (70.0%) of the physicians were specialists, and 80.5% of the enrolled prescriptions were collected from pediatric outpatient clinics. Most of the prescriptions in our study included antibiotics (116/58%). The most commonly prescribed antibiotic family was ampicillin/sulbactam or amoxicillin/clavulanic acid (53/26.5%), followed by first–generation cephalosporin (25/12.5%) and third–generation cephalosporin (20/10%). Macrolides and second-generation cephalosporins were prescribed less frequently, in 16 (8%) and 2 (1%) patients, respectively.

Table 1 Baseline characteristics, n (%).
Baseline characteristics
Count
GenderMale104 (52.0)
Female96 (48.0)
Current diagnosisAcute pharyngitis59 (29.5)
Acute tonsillitis38 (19.0)
Acute sinusitis27 (13.5)
Acute otitis media13 (6.5)
Acute rhinitis and/or common cold63 (31.5)
Physician gradeGeneral practitioner60 (30.0)
Specialist (pediatrician and ENT)140 (70.0)
Outpatient clinicPediatric161 (80.5)
ENT39 (19.5)
Type of drug (antibiotics)No84 (42)
Yes116 (58)
Family of antibiotic prescribedPenicillin family "ampicillin/sulbactam or amoxicillin/clavulanic acid"53 (26.5)
First-generation cephalosporin25 (12.5)
Macrolides16 (8.0)
Second-generation cephalosporin2 (1.0)
Third-generation cephalosporin20 (10.0)
No84 (42.0)

Table 2 shows that 32.5% of patients were prescribed antihistaminic drugs. The most commonly prescribed antihistamines were from the second-generation family (24%), followed by those from the first-generation group (8.5%). Of the enrolled patients, 48.5% were prescribed oral nasal decongestants, of whom 72.2% had oral nasal decongestants containing pseudoephedrine, 26.8% had phenylephrine containing forms, and only 1% had a phenylpropanolamine-containing type. In all, 30.5% of patients had antitussive medicines, while 85.0% had antipyretics. According to the type of antipyretic, 48% and 22.8% of patients had received ibuprofen and paracetamol, respectively, whereas 14.6% had received diclofenac Na/K and combinations in each group. According to the route of administration of antibiotics, 37.0% of them were prescribed orally, 10.5% by injection and both routes in each individual category. Seventy-two percent of patients had laboratory investigations in the form of complete blood count (CBC) and C-reactive protein (CRP).

Table 2 Baseline characteristics regarding type of prescribed drug, n (%).
Baseline characteristics regarding type of prescribed drug
Count
AntihistaminesYes65 (32.5)
No135 (67.5)
Family of antihistaminesFirst-generation antihistaminic17 (8.5)
Second-generation antihistaminic48 (24.0)
No135 (67.5)
Oral nasal decongestantYes97 (48.5)
No103 (51.5)
Type of oral nasal decongestantOral nasal decongestant containing pseudoephedrine70 (72.2)
Containing phenylephrine26 (26.8)
Containing phenylpropanolamine1 (1.0)
Antitussive medicineNo139 (69.5)
Yes61 (30.5)
Antipyretic medicineYes170 (85.0)
No30 (15.0)
Type of antipyreticsParacetamol39 (22.8)
Ibuprofen82 (48.0)
Diclofenac Na/K25 (14.6)
Combinations25 (14.6)
Route of administration of antibioticsOrally74 (37.0)
Injection21 (10.5)
Both21 (10.5)
No84 (42.0)
Laboratory investigations: Complete blood count and C-reactive proteinNot done56 (28.0)
Done144 (72.0)

According to seeking other medical services, 19.5%, 12.5%, and 5.5% of patients sought pharmacies, private clinics, and hospitals, respectively. According to parents’ satisfaction, 77.5% of them were satisfied. According to vaccination history, 84.5% of patients had received compulsory immunization schedule only, while 15.5% had received additional recommended vaccines. According to the family education, 97.5% of patients had educated mothers, while 92.0% of them had educated fathers, as shown in Table 3.

Table 3 Summary of study population attitude and practice regarding the provided medical service, n (%).
Attitude and practice regarding the provided medical service
Count
Seeking other medical serviceNo125 (62.5)
Pharmacy39 (19.5)
Hospital11 (5.5)
Private clinic25 (12.5)
Parents’ satisfactionSatisfied155 (77.5)
Unsatisfied45 (22.5)
Vaccination historyCompulsory immunization schedule only169 (84.5)
Additional recommended vaccines31 (15.5)
Mother's educationEducated195 (97.5)
Uneducated5 (2.5)
Father's educationEducated184 (92.0)
Uneducated16 (8.0)

There was a significant relationship between antibiotic prescription and antitussive medicine, antipyretics, type of antipyretic, route of administration of antibiotics, laboratory investigations (CBC and CRP), total leukocyte count (TLC) in number, TLC (differential count), and CRP (Table 4).

Table 4 Intergroup comparison between the study populations when classified according to antibiotic administration status, n (%).

Antibiotic prescription
P value
Yes
No
Antitussive medicineNo88 (76.5)51 (60.0)0.012
Yes27 (23.5)34 (40.0)
AntipyreticsYes107 (93.0)63 (74.1)< 0.001
No8 (7.0)22 (25.9)
Type of antipyreticParacetamol12 (11.1)27 (42.9)< 0.001
Ibuprofen57 (52.8)25 (39.7)
Diclofenac Na/K16 (14.8)9 (14.3)
Combinations23 (21.3)2 (3.2)
Route of administration of antibioticsOrally73 (63.5)1 (1.2)< 0.001
Injection21 (18.3)0 (0.0)
Both21 (18.3)0 (0.0)
No0 (0.0)84 (98.8)
Laboratory investigations: Complete blood count and CRPNot done41 (35.7)15 (17.6)0.005
Done74 (64.3)70 (82.4)
TLC in numberHigh20 (26.7)6 (8.6)0.005
Normal55 (73.3)64 (91.4)
TLC (differential count)Normal52 (69.3)57 (81.4)0.002
Neutrophilia18 (24.0)3 (4.3)
Lymphocytosis5 (6.7)8 (11.4)
Eosinophilia0 (0.0)1 (1.4)
Monocytosis0 (0.0)1 (1.4)
CRPPositive31 (41.3)3 (4.6)< 0.001
Negative44 (58.7)62 (95.4)

Table 5 shows a significant relationship between antibiotic prescription and father’s education.

Table 5 Correlation between antibiotic administration in children with upper respiratory tract infections and other parameters.
Antibiotic prescription
P value
Yes
No

Compliance to treatmentRegular102 (88.7)79 (92.9)0.311
Irregular13 (11.3)6 (7.1)
Response to treatmentGood90 (78.3)65 (76.5)0.764
Not good25 (21.7)20 (23.5)
Side effects appearance (rash, diarrhea, gastrointestinal upsets, etc.)No96 (83.5)77 (90.6)0.146
Yes19 (16.5)8 (9.4)
Seeking other medical serviceNo75 (65.2)50 (58.8)0.638
Pharmacy19 (16.5)20 (23.5)
Hospital6 (5.2)5 (5.9)
Private clinic15 (13.0)10 (11.8)
Parents’ satisfactionSatisfied91 (79.1)64 (75.3)0.521
Unsatisfied24 (20.9)21 (24.7)
Vaccination historyCompulsory immunization schedule only102 (88.7)67 (78.8)0.057
Additional recommended vaccines13 (11.3)18 (21.2)
Mother's educationEducated112 (97.4)83 (97.6)1
Uneducated3 (2.6)2 (2.4)
Father's educationEducated101 (87.8)83 (97.6)0.011
Uneducated14 (12.2)2 (2.4)
DISCUSSION

This study shows that 52.0% of the enrolled patients were males. In total, 29.5% of the study population had acute pharyngitis, 19.0% had acute tonsillitis, 13.5% had acute sinusitis, 6.5% had acute otitis media, and 31.5% had acute rhinitis and/or common cold. Seventy percent of physicians were specialists, and 80.5% of the enrolled prescriptions were collected from pediatric outpatient clinics. Fifty-eight percent of patients had antibiotics in their prescriptions.

In a study by Butt et al[8] on the outpatient pediatric population with URTIs, it was found that 45% of them had antibiotics in their prescriptions. The majority of antibiotics were prescribed by general/family practice physicians, followed by pediatricians, and otolaryngologists.

Most of the prescriptions in our study included antibiotics (116/58%). The most commonly prescribed antibiotic family was ampicillin/sulbactam or amoxicillin/clavulanic acid (53/26.5%), followed by first-generation cephalosporin (25/12.5%) and third-generation cephalosporin (20/10%). Macrolides and second-generation cephalosporins were prescribed less frequently in 16 (8%) and 2 (1%) patients, respectively.

The highest use of antibiotics was reported in the penicillin group (26.5%). These agents are suggested by the standard guidelines for URTIs[9].

In another study by Eibach et al[10], cephalosporins are widely utilized as empirical treatments in primary care clinics due to their low toxicity. However, it is important to note that they might also contribute to the development and spread of multi-drug-resistant infections.

Most of our study population did not have antitussive medications (139/69.5%); regarding the pattern of oral nasal decongestant prescription, 48.5% of our study population had this type of drug. Of those 97 patients, most of them had decongestants containing pseudoephedrine (70/72.2%), followed by those containing phenylephrine and phenylpropanolamine (26/26.8% and 1/1%), respectively.

Cheng et al[11] revealed that antihistamines for systemic use have been the most often prescribed drugs for cough and cold in viral respiratory tract infections, followed by mucolytic agents, across all age groups. Although studies have not demonstrated any therapeutic advantages of antihistamines compared to placebos in relieving cold-induced sneezing or nasal symptoms in children, it is still not advisable to use antihistamines alone in kids due to the potential for adverse reactions.

Most of the prescriptions (135/67.5%) included in our study did not involve antihistamines, while only 65 (32.5%) patients had antihistamines. These findings are in accordance with Lakshmi et al[12], who also reported a lower percentage of population with URTIs who had an antihistaminic prescription.

There was a significant relationship between antibiotic prescription and antitussive medicine, antipyretics, type of antipyretic, route of administration of antibiotics, laboratory investigations (CBC and CRP), TLC in number, TLC (differential count), CRP, and father’s education. According to the pattern of antipyretic drug prescriptions, most of our study population had antipyretics (170/85%). The most commonly prescribed antipyretic drug was ibuprofen (82/48%), followed by paracetamol (39/22.8%). Diclofenac Na/K or drug combinations were prescribed in (25/14.6%) of the enrolled prescriptions for each group.

Lakshmi et al[12] observed that 130 cases (71.8%) received antipyretic therapy. Particularly, the proportion of preschoolers (76.7%) receiving the therapy was greater than schoolchildren (57.4%). The prevalent pattern observed was the prescription of a single antipyretic medication, whereas a combination of two alternating medicines was administered in 25.3% of cases. The most recommended medications were paracetamol and ibuprofen, either used alone or in alternating doses. Ibuprofen was provided to 54% of preschoolers and 64.7% of schoolchildren.

Most of our study population (155/77.5%)was satisfied with their prescriptions, while the rest of our study population (45/22.5%) was unsatisfied.

The results are consistent with those reported by Zyoud et al[13], who found that pediatricians and parents have a trusting relationship. Most parents have confidence in the prescriptions and information provided by pediatricians, and only a few of them would change pediatricians if antibiotics were overprescribed or underprescribed for URTIs in kids.

We recommend that future studies include private healthcare facilities. More treatment details should be recorded such as the appropriateness and length of antibiotic use, with the indication for culture before antibiotic therapy. This will provide significant information to guide antibiotic stewardships strategies. Future surveys should be conducted throughout multiple time points for a more robust estimate of inpatient antibiotic prescribing in Egypt. Studies should also be conducted to assess the relationship of attitudes to actual antimicrobial prescribing; thus, there may have been information bias toward providing answers that the respondents thought the investigators wanted to hear, leading to underestimates of the prevalence of inappropriate attitudes, and prescribing behaviors. Measuring antibiotic consumption and prescription audit to determine the appropriate use of antibiotics and whether or not the interventions are effective.

CONCLUSION

Overprescription of antibiotics is a significant issue among clinicians in pediatric outpatient clinics. Pediatric clinicians should aim to reduce antibiotic use by addressing three fundamental questions for each patient with a suspected infection: (1) Do antibiotics need to be prescribed; (2) What is the appropriate dose thereof; and (3) What is the optimal duration of treatment. Stewardship of drugs, particularly antibiotics is a must, to prevent the development of drug resistance.

Footnotes

Provenance and peer review: Unsolicited article; Externally peer reviewed.

Peer-review model: Single blind

Specialty type: Pediatrics

Country of origin: Egypt

Peer-review report’s classification

Scientific Quality: Grade D

Novelty: Grade B

Creativity or Innovation: Grade C

Scientific Significance: Grade D

P-Reviewer: Upadhyay H S-Editor: Luo ML L-Editor: Filipodia P-Editor: Yu HG

References
1.  Havers FP, Hicks LA, Chung JR, Gaglani M, Murthy K, Zimmerman RK, Jackson LA, Petrie JG, McLean HQ, Nowalk MP, Jackson ML, Monto AS, Belongia EA, Flannery B, Fry AM. Outpatient Antibiotic Prescribing for Acute Respiratory Infections During Influenza Seasons. JAMA Netw Open. 2018;1:e180243.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 110]  [Cited by in RCA: 138]  [Article Influence: 19.7]  [Reference Citation Analysis (0)]
2.  Alfayate Miguélez S, Garcia-Marcos L. Rational use of antimicrobials in the treatment of upper airway infections. J Pediatr (Rio J). 2020;96 Suppl 1:111-119.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 6]  [Cited by in RCA: 1]  [Article Influence: 0.2]  [Reference Citation Analysis (0)]
3.  Goebel MC, Trautner BW, Grigoryan L. The Five Ds of Outpatient Antibiotic Stewardship for Urinary Tract Infections. Clin Microbiol Rev. 2021;34:e0000320.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 25]  [Cited by in RCA: 56]  [Article Influence: 14.0]  [Reference Citation Analysis (0)]
4.  Brook I. Microbiology of sinusitis. Proc Am Thorac Soc. 2011;8:90-100.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 88]  [Cited by in RCA: 92]  [Article Influence: 6.6]  [Reference Citation Analysis (0)]
5.  Korppi M, Heikkilä P, Palmu S, Huhtala H, Csonka P. Antibiotic prescribing for children with upper respiratory tract infection: a Finnish nationwide 7-year observational study. Eur J Pediatr. 2022;181:2981-2990.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1]  [Cited by in RCA: 5]  [Article Influence: 1.7]  [Reference Citation Analysis (0)]
6.  Hurst JH, Kelly MS. Leveraging the human microbiota to target bacterial respiratory pathogens: new paths toward an expanded antimicrobial armamentarium. mBio. 2023;14:e0085423.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1]  [Cited by in RCA: 1]  [Article Influence: 0.5]  [Reference Citation Analysis (0)]
7.  van Doorn HR, Yu H.   Viral Respiratory Infections. In: Ryan ET, Hill DR, Solomon T, Aronson NE, Endy TP, editor. Hunter's Tropical Medicine and Emerging Infectious Diseases. Netherlands: Elsevier, 2020: 284-288.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 12]  [Cited by in RCA: 15]  [Article Influence: 3.0]  [Reference Citation Analysis (0)]
8.  Butt AA, Navasero CS, Thomas B, Marri SA, Katheeri HA, Thani AA, Khal AA, Khan T, Abou-Samra AB. Antibiotic prescription patterns for upper respiratory tract infections in the outpatient Qatari population in the private sector. Int J Infect Dis. 2017;55:20-23.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 29]  [Cited by in RCA: 24]  [Article Influence: 3.0]  [Reference Citation Analysis (0)]
9.  Mishra S, Srivastava P, Sunder S, Mishra AK, Tanti SK. Evaluation and optimization of antibiotic usage in upper respiratory tract infections in children at a tertiary care outpatient department: A clinical audit. Indian J Pharmacol. 2022;54:13-18.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (0)]
10.  Eibach D, Belmar Campos C, Krumkamp R, Al-Emran HM, Dekker D, Boahen KG, Kreuels B, Adu-Sarkodie Y, Aepfelbacher M, Park SE, Panzner U, Marks F, May J. Extended-spectrum beta-lactamase producing Enterobacteriaceae causing bloodstream infections in rural Ghana, 2007-2012. Int J Med Microbiol. 2016;306:249-254.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 29]  [Cited by in RCA: 40]  [Article Influence: 4.4]  [Reference Citation Analysis (0)]
11.  Cheng CL, Kao Yang YH, Liu CC, Lee PI. A retrospective study on the usage of cough and cold medications in viral respiratory tract infections in Taiwanese children. Pharmacoepidemiol Drug Saf. 2014;23:36-42.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 2]  [Cited by in RCA: 2]  [Article Influence: 0.2]  [Reference Citation Analysis (0)]
12.  Lakshmi R, Geetha D, Vijayasamundeeswari P. Assessing the knowledge, attitude, and practice on antibiotic use in under-5 children with respiratory tract infection among mothers attending a pediatric outpatient department. J Public Health. 2021;29:325-331.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (0)]
13.  Zyoud SH, Abu Taha A, Araj KF, Abahri IA, Sawalha AF, Sweileh WM, Awang R, Al-Jabi SW. Parental knowledge, attitudes and practices regarding antibiotic use for acute upper respiratory tract infections in children: a cross-sectional study in Palestine. BMC Pediatr. 2015;15:176.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 26]  [Cited by in RCA: 31]  [Article Influence: 3.1]  [Reference Citation Analysis (0)]